Discordant effects of rosiglitazone on novel inflammatory biomarkers.
Gada E, Owens AW, Gore MO, See R, Abdullah SM, Ayers CR, Rohatgi A, Khera A, de Lemos JA, McGuire DK.
Gada E, et al. Among authors: see r.
Am Heart J. 2013 Apr;165(4):609-14. doi: 10.1016/j.ahj.2013.01.006. Epub 2013 Feb 16.
Am Heart J. 2013.
PMID: 23537979
Clinical Trial.